Context Therapeutics Reports Third Quarter 2023 Operating and Financial Results

Go back to Context Therapeutics Reports Third Quarter 2023 Operating and Financial Results
(NASDAQ: CNTX) Delayed: 0.50 -0.03 (5.66%)
Previous Close $0.53    52 Week High
Open $0.53    52 Week Low
Day High $0.53    P/E N/A 
Day Low $0.49    EPS
Volume 3,332,904